Upgrade to SI Premium - Free Trial

TD Cowen Upgrades PTC Therapeutics (PTCT) to Buy

May 8, 2026 2:57 AM
TD Cowen analyst Joseph Thome upgraded PTC Therapeutics (NASDAQ: PTCT) from Hold to Buy with a price target of $90.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Upgrades